Literature DB >> 269396

Opiate-dependent modulation of adenylate cyclase.

S K Sharma, W A Klee, M Nirenberg.   

Abstract

Reactions mediated by the opiate receptors that inhibit adenylate cyclase (EC 4.6.1.1) are closely coupled to subsequent reactions that gradually increase adenylate cyclase activity of neuroblastoma X glioma NG108-15 hybrid cells. Opiate-treated cells have higher basal-, prostaglandin E1-, and 2-chloroadenosine-stimulated activities than do control cells. However, NaF or guanosine 5'-(beta, gamma-imido)triphosphate abolishes most of the differences in adenylate cyclase activity observed with homogenates from control and opiate-treated cells. Cycloheximide blocked some, but not all, of the opiate-dependent increase in adenylate cyclase activity. These results suggest that the opiate-dependent increase in adenylate cyclase is due to conversion of adenylate cyclase to a form with altered activity. Protein synthesis also is required for part of the opiate effect. We propose that activity of adenylate cyclase determines the rate of conversion of the enzyme from one form to the other and that opiates, by inhibiting adenylate cyclase, alter the relative abundance of low- and high-activity forms of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 269396      PMCID: PMC431562          DOI: 10.1073/pnas.74.8.3365

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Neuroblastoma adenylate cyclase. Role of 2-chloroadenosine, prostaglandin E1, and guanine nucleotides in regulation of activity.

Authors:  A J Blume; C J Foster
Journal:  J Biol Chem       Date:  1976-06-10       Impact factor: 5.157

2.  Morphine-like drugs inhibit the stimulation of E prostaglandins of cyclic AMP formation by rat brain homogenate.

Authors:  H O Collier; A C Roy
Journal:  Nature       Date:  1974-03-01       Impact factor: 49.962

3.  The activation of adenylate cyclase. II. The postulated presence of (A) adenylate cyclase in a phospho (inhibited) form (B) a dephospho (activated) form with a cyclic adenylate stimulated membrane protein kinase.

Authors:  A Constantopoulos; V A Najjar
Journal:  Biochem Biophys Res Commun       Date:  1973-08-06       Impact factor: 3.575

4.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

5.  Induction of functional beta-adrenergic receptors in HeLa cells.

Authors:  J F Tallman; C C Smith; R C Henneberry
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

6.  Activation and inhibition of fat cell adenylate cyclase by fluoride.

Authors:  V C Manganiello; M Vaughan
Journal:  J Biol Chem       Date:  1976-10-25       Impact factor: 5.157

7.  Modification of adenylate cyclase activity in LM cells by manipulation of the membrane phospholipid composition in vivo.

Authors:  V H Engelhard; J D Esko; D R Storm; M Glaser
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

8.  Fatty acids as modulators of membrane functions: catecholamine-activated adenylate cyclase of the turkey erythrocyte.

Authors:  J Orly; M Schramm
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

9.  Mechanism of activation of adenylate cyclase by cholera toxin.

Authors:  N Sahyoun; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

10.  5'-Guanylylimidodiphosphate, a potent activator of adenylate cyclase systems in eukaryotic cells.

Authors:  C Londos; Y Salomon; M C Lin; J P Harwood; M Schramm; J Wolff; M Rodbell
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

View more
  58 in total

1.  Activation and internalization of the mu-opioid receptor by the newly discovered endogenous agonists, endomorphin-1 and endomorphin-2.

Authors:  K McConalogue; E F Grady; J Minnis; B Balestra; M Tonini; N C Brecha; N W Bunnett; C Sternini
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

2.  Dissociation of tolerance and dependence for opioid peripheral antinociception in rats.

Authors:  K O Aley; J D Levine
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

Review 3.  Visualizing activation of opioid circuits by internalization of G protein-coupled receptors.

Authors:  Kevin Sinchak; Paul Micevych
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

4.  Reciprocal modulation of phospholipase Cbeta isoforms: adaptation to chronic morphine.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; Alan R Gintzler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

Review 5.  Opioid receptor regulation.

Authors:  Mark von Zastrow
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 6.  Post-transcriptional regulation of opioid receptors in the nervous system.

Authors:  Li-Na Wei; Ping-Yee Law; Horace H Loh
Journal:  Front Biosci       Date:  2004-05-01

7.  Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.

Authors:  Jenny Morgenweck; Kevin J Frankowski; Thomas E Prisinzano; Jeffrey Aubé; Laura M Bohn
Journal:  Neuropharmacology       Date:  2015-08-25       Impact factor: 5.250

Review 8.  Temporal and concentration-dependent effects of oestradiol on neural pathways mediating sexual receptivity.

Authors:  P Micevych; K Sinchak
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

Review 9.  Regulation of opioid receptors by endocytic membrane traffic: mechanisms and translational implications.

Authors:  Mark von Zastrow
Journal:  Drug Alcohol Depend       Date:  2010-03-24       Impact factor: 4.492

10.  Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.

Authors:  Elena H Chartoff; Matthew F Barhight; Steve D Mague; Allison M Sawyer; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2009-01-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.